United States · FDA National Drug Code directory

Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72162-2565_b9bbd941-4d8b-434f-8c61-0a4fb2e9a989
Product NDC
72162-2565
Form
TABLET, FILM COATED
Composition / generic term
Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate
Labeler
Bryant Ranch Prepack
Marketing category
ANDA
Marketing start / end (source format)
20210330
Source listing expiry
20261231

Source-listed ingredients

  • EFAVIRENZ — 600 mg/1
  • EMTRICITABINE — 200 mg/1
  • TENOFOVIR DISOPROXIL FUMARATE — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET, FILM COATED in 1 BOTTLE (72162-2565-3) · 72162-2565-3

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →